Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated October 14, 2020, titled "SPARC Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of SDN-037 for the Treatment of Inflammation and Pain Associated with Ocular Surgery".